Altered levels of the soluble IL-1, IL-4 and TNF receptors, as well as the IL-1 receptor antagonist, in intermittent allergic rhinitis

International Archives of Allergy and Immunology

Volumn 134, Issue 3, 2004, Pages 227-232

  Benson, Mikael ^a,b   Wennergren, Göran ^b   Fransson, Mattias ^a   Cardell, Lars Olaf ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Cytokines, soluble; Interleukins; Receptors; Rhinitis

Indexed keywords

CYTOKINE RECEPTOR; GRASS POLLEN EXTRACT; IMMUNOGLOBULIN E; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 4; TUMOR NECROSIS FACTOR;

ALLERGIC RHINITIS; ALLERGY TEST; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GRASS POLLEN; HUMAN; IMMUNOPATHOGENESIS; MALE; NOSE MUCUS; PRIORITY JOURNAL; PROVOCATION TEST; SCORING SYSTEM;

ADOLESCENT; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; MIDDLE AGED; NASAL LAVAGE FLUID; NASAL PROVOCATION TESTS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-4; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR; RHINITIS, ALLERGIC, SEASONAL; SIALOGLYCOPROTEINS; TIME FACTORS;

EID: 3042670323     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078770     Document Type: Article

References (23)

1. Christodoulopoulos P, Cameron L, Durham S, Hamid Q: Molecular pathology of allergic disease. II: Upper airway disease. J Allergy Clin Immunol 2000;105:211-223.
2. Bradding P, Mediwake R, Feather IH, Madden J, Church MK, Holgate ST, Howarth PH: TNF alpha is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy 1995;25:406-415.
3. Benson M, Adner M, Cardell LO: Cytokines and their receptors in allergic rhinitis: Relations to the Th2 hypothesis in allergy. Clin Exp Allergy 2001;31:361-368.
4. Benson M, Strannegård I-L, Strannegård Ö, Wennergren G: Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFNgamma, IL-1beta, TNF-alpha, or neutrophils. J Allergy Clin Immunol 2000;106:307-312.
5. Heaney ML, Golde DW: Soluble receptors in human disease. J Leukoc Biol 1998;64:135-146.
6. Peters M, Jacobs M, Ehler P, et al: The function of the soluble IL-6 receptor in vivo: Sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J Exp Med 1996;183:1399-1406.
7. Jung T, Wagner K, Neumann C, Heusser CH: Enhancement of human IL-4 activity by soluble IL-4 receptors in vitro. Eur J Immunol 1999;29:864-871.
8. Borish LC, Nelson HS, Corren J, Bensch G, Busse WW, Whitmore JB, Agosti JM: Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. J Allergy Clin Immunol 2001;107:963-970.
9. Benson M, Strannegård IL, Wennergren G, Strannegård Ö: Cytokines in nasal fluids from school children with seasonal allergic rhinitis. Pediatr Allergy Immunol 1997;8:143-149.
10. Bachert C, van Kempen M, Van Cauwenberge P: Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol 1999;118:375-379.
11. Benson M, Strannegård IL, Wennergren G, Strannegård Ö: Increase of the soluble IL-4 receptor (SIL-4R) and positive correlation between SIL-4R and IgE in nasal fluids from school children with allergic rhinitis. Allergy Asthma Proc 2000;21:1-7.
12. Kato M, Kato Y, Takeuchi K, Nakashima I: Local levels of soluble tumor necrosis factor receptors in patients with allergic rhinitis are regulated by amount of antigen. Arch Otolaryngol Head Neck Surg 2000;126:997-1000.
13. Malm L, Gerth van Wijk R, Bachert C: Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. International Committee on Objective Assessment of the Nasal Airways, International Rhinologic Society. Rhinology 2000;38:1-6.
14. Linden M, Svensson C, Andersson E, Andersson M, Greiff L, Persson CG: Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocyte-macrophage colony-stimulating factor and interleukin-5. Am J Respir Crit Care Med 2000;162:1705-1708.
15. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wuthrich B; EAACI (the European Academy of Allergology and Clinical Immunology nomenclature task force). A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813-824.
16. Widmer MB, Blosch CM: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-147.
17. Gronborg H, Bisgaard H, Romeling F, Mygind N: Early and late nasal symptom response to allergen challenge. The effect of pretreatment with a glucocorticosteroid spray. Allergy 1993;48:87-93.
18. Wright ED, Christodoulopoulos P, Small P, Frenkiel S, Hamid Q: Th-2 type cytokine receptors in allergic rhinitis and in response to topical steroids. Laryngoscope 1998;108:1528-1533.
19. Kotsimbos TC, Ghaffar O, Minshall EM, Humbert M, Durham SR, Pfister R, Menz G, Kay AB, Hamid QA: Expression of the IL-4 receptor alpha-subunit is increased in bronchial biopsy specimens from atopic and nonatopic asthmatic subjects. J Allergy Clin Immunol 1998;102:859-866.
20. Glare EM, Divjak M, Rolland JM, Walters EH: Asthmatic airway biopsy specimens are more likely to express the IL-4 alternative splice variant IL-4delta2. J Allergy Clin Immunol 1999;104:978-982.
21. Sim TC, Grant JA, Hilsmeier KA, Fukuda Y, Alam R: Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med 1994;149:339-344.
22. Bachert C, Wagenmann M, Hauser U: Proinflammatory cytokines: Measurement in nasal secretion and induction of adhesion receptor expression. Int Arch Allergy Immunol 1995;107:106-108.
23. Hirsch E, Irikura VM, Paul SM, Hirsh D: Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 1996;93:11008-11013.